Top compounds associated with response to EGR2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.01
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA B02 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.01
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.075 0.01
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA Vorinostat gCSI pan-cancer AAC -0.12 0.02
mRNA PIK-93 GDSC1000 pan-cancer AAC 0.069 0.02
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
Download CSV